
A multi-center randomized phase II clinical study of bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for Chinese patients with metastatic colorectal cancer
Cao, Ranhua, Zhang, Shuai, Ma, Dedong, Hu, LikuanVolume:
32
Langue:
english
Journal:
Medical Oncology
DOI:
10.1007/s12032-014-0325-9
Date:
January, 2015
Fichier:
PDF, 267 KB
english, 2015